APO Research
Talk to an analyst

APO RESEARCH · REPORT

Corticosteroids

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Corticosteroids Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchCorticosteroids Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Corticosteroids Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Corticosteroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Corticosteroids Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Corticosteroids Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Corticosteroids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Corticosteroids market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Corticosteroids market include Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca, Sumitomo and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Corticosteroids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Corticosteroids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Corticosteroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Corticosteroids market size, projected growth trends, production technologies, key applications, and end-use industries.

Corticosteroids Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Pfizer

GlaxoSmithKline

AstraZeneca

Sumitomo

Cipla

Corticosteroids Segment by Type

Cream

Injection

Other

Corticosteroids Segment by Application

Dermatology

Endocrinology

Allergy

Other

Corticosteroids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Corticosteroids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Corticosteroids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Corticosteroids significant trends, drivers, influence factors in global and regions.

6. To analyze Corticosteroids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Corticosteroids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Corticosteroids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Corticosteroids industry.

Chapter 3: Detailed analysis of Corticosteroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Corticosteroids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Corticosteroids Industry Trends Table 2. Corticosteroids Industry Drivers Table 3. Corticosteroids Industry Opportunities and Challenges Table 4. Corticosteroids Industry Restraints Table 5. Global Corticosteroids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Corticosteroids Revenue Share by Company (2021-2026) Table 7. Global Corticosteroids Sales Volume by Company (kg) & (2021-2026) Table 8. Global Corticosteroids Sales Volume Share by Company (2021-2026) Table 9. Global Corticosteroids Average Price (US$/g) of Company (2021-2026) Table 10. Global Corticosteroids Company Ranking, (2024-2026) & (USD Million) Table 11. Global Corticosteroids Key Company Manufacturing Base & Headquarters Table 12. Global Corticosteroids Company, Product Type & Application Table 13. Global Corticosteroids Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Corticosteroids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cream Table 18. Significant Companies of Injection Table 19. Significant Companies of Other Table 20. Global Corticosteroids Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Corticosteroids Sales Volume by Type (2021-2026) & (kg) Table 22. Global Corticosteroids Sales Volume by Type (2027-2032) & (kg) Table 23. Global Corticosteroids Sales Volume Share by Type (2021-2026) Table 24. Global Corticosteroids Sales Volume Share by Type (2027-2032) Table 25. Global Corticosteroids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Corticosteroids Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Corticosteroids Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Corticosteroids Sales Value Share by Type (2021-2026) Table 29. Global Corticosteroids Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dermatology Table 31. Significant Companies of Endocrinology Table 32. Significant Companies of Allergy Table 33. Significant Companies of Other Table 34. Global Corticosteroids Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 35. Global Corticosteroids Sales Volume by Application (2021-2026) & (kg) Table 36. Global Corticosteroids Sales Volume by Application (2027-2032) & (kg) Table 37. Global Corticosteroids Sales Volume Share by Application (2021-2026) Table 38. Global Corticosteroids Sales Volume Share by Application (2027-2032) Table 39. Global Corticosteroids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Corticosteroids Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Corticosteroids Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Corticosteroids Sales Value Share by Application (2021-2026) Table 43. Global Corticosteroids Sales Value Share by Application (2027-2032) Table 44. Global Corticosteroids Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 45. Global Corticosteroids Sales by Region (2021-2026) & (kg) Table 46. Global Corticosteroids Sales Market Share by Region (2021-2026) Table 47. Global Corticosteroids Sales by Region (2027-2032) & (kg) Table 48. Global Corticosteroids Sales Market Share by Region (2027-2032) Table 49. Global Corticosteroids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Corticosteroids Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Corticosteroids Sales Value Share by Region (2021-2026) Table 52. Global Corticosteroids Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Corticosteroids Sales Value Share by Region (2027-2032) Table 54. Global Corticosteroids Market Average Price (US$/g) by Region (2021-2026) Table 55. Global Corticosteroids Market Average Price (US$/g) by Region (2027-2032) Table 56. Global Corticosteroids Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 57. Global Corticosteroids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Corticosteroids Sales by Country (2021-2026) & (kg) Table 59. Global Corticosteroids Sales Market Share by Country (2021-2026) Table 60. Global Corticosteroids Sales by Country (2027-2032) & (kg) Table 61. Global Corticosteroids Sales Market Share by Country (2027-2032) Table 62. Global Corticosteroids Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Corticosteroids Sales Value Market Share by Country (2021-2026) Table 64. Global Corticosteroids Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Corticosteroids Sales Value Market Share by Country (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 69. Sanofi Corticosteroids Product Portfolio Table 70. Sanofi Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Corticosteroids Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Novartis Corticosteroids Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Merck Corticosteroids Product Portfolio Table 85. Merck Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Pfizer Corticosteroids Product Portfolio Table 90. Pfizer Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Corticosteroids Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. AstraZeneca Corticosteroids Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Sumitomo Company Information Table 102. Sumitomo Business Overview Table 103. Sumitomo Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Sumitomo Corticosteroids Product Portfolio Table 105. Sumitomo Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Corticosteroids Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Cipla Corticosteroids Product Portfolio Table 110. Cipla Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Corticosteroids Distributors List Table 114. Corticosteroids Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Corticosteroids Product Image Figure 2. Global Corticosteroids Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 4. Global Corticosteroids Sales (2021-2032) & (kg) Figure 5. Global Corticosteroids Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Corticosteroids Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cream Image Figure 10. Injection Image Figure 11. Other Image Figure 12. Global Corticosteroids Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Corticosteroids Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Corticosteroids Sales Volume Share by Type (2021-2032) Figure 15. Global Corticosteroids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Corticosteroids Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Corticosteroids Sales Value Share by Type (2021-2032) Figure 18. Dermatology Image Figure 19. Endocrinology Image Figure 20. Allergy Image Figure 21. Other Image Figure 22. Global Corticosteroids Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global Corticosteroids Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Corticosteroids Sales Volume Share by Application (2021-2032) Figure 25. Global Corticosteroids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Corticosteroids Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Corticosteroids Sales Value Share by Application (2021-2032) Figure 28. Global Corticosteroids Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 29. Global Corticosteroids Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Corticosteroids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Corticosteroids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 33. North America Corticosteroids Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Corticosteroids Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Corticosteroids Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 39. South America Corticosteroids Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Corticosteroids Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Corticosteroids Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Corticosteroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Corticosteroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Corticosteroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Corticosteroids Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Corticosteroids Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Cream
  • Injection
  • Other
Applications
  • Dermatology
  • Endocrinology
  • Allergy
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Sumitomo
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Corticosteroids Sales Value (2021-2032)
  4. 1.2.2 Global Corticosteroids Sales Volume (2021-2032)
  5. 1.2.3 Global Corticosteroids Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Corticosteroids Market Dynamics
  1. 2.1 Corticosteroids Industry Trends
  2. 2.2 Corticosteroids Industry Drivers
  3. 2.3 Corticosteroids Industry Opportunities and Challenges
  4. 2.4 Corticosteroids Industry Restraints
3 Corticosteroids Market by Company
  1. 3.1 Global Corticosteroids Company Revenue Ranking in 2025
  2. 3.2 Global Corticosteroids Revenue by Company (2021-2026)
  3. 3.3 Global Corticosteroids Sales Volume by Company (2021-2026)
  4. 3.4 Global Corticosteroids Average Price by Company (2021-2026)
  5. 3.5 Global Corticosteroids Company Ranking (2024-2026)
  6. 3.6 Global Corticosteroids Company Manufacturing Base and Headquarters
  7. 3.7 Global Corticosteroids Company Product Type and Application
  8. 3.8 Global Corticosteroids Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Corticosteroids Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Corticosteroids Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Corticosteroids Market by Type
  1. 4.1 Corticosteroids Type Introduction
  2. 4.1.1 Cream
  3. 4.1.2 Injection
  4. 4.1.3 Other
  5. 4.2 Global Corticosteroids Sales Volume by Type
  6. 4.2.1 Global Corticosteroids Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Corticosteroids Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Corticosteroids Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Corticosteroids Sales Value by Type
  10. 4.3.1 Global Corticosteroids Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Corticosteroids Sales Value by Type (2021-2032)
  12. 4.3.3 Global Corticosteroids Sales Value Share by Type (2021-2032)
5 Corticosteroids Market by Application
  1. 5.1 Corticosteroids Application Introduction
  2. 5.1.1 Dermatology
  3. 5.1.2 Endocrinology
  4. 5.1.3 Allergy
  5. 5.1.4 Other
  6. 5.2 Global Corticosteroids Sales Volume by Application
  7. 5.2.1 Global Corticosteroids Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Corticosteroids Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Corticosteroids Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Corticosteroids Sales Value by Application
  11. 5.3.1 Global Corticosteroids Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Corticosteroids Sales Value by Application (2021-2032)
  13. 5.3.3 Global Corticosteroids Sales Value Share by Application (2021-2032)
6 Corticosteroids Regional Sales and Value Analysis
  1. 6.1 Global Corticosteroids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Corticosteroids Sales by Region (2021-2032)
  3. 6.2.1 Global Corticosteroids Sales by Region: 2021-2026
  4. 6.2.2 Global Corticosteroids Sales by Region (2027-2032)
  5. 6.3 Global Corticosteroids Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Corticosteroids Sales Value by Region (2021-2032)
  7. 6.4.1 Global Corticosteroids Sales Value by Region: 2021-2026
  8. 6.4.2 Global Corticosteroids Sales Value by Region (2027-2032)
  9. 6.5 Global Corticosteroids Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Corticosteroids Sales Value (2021-2032)
  12. 6.6.2 North America Corticosteroids Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Corticosteroids Sales Value (2021-2032)
  15. 6.7.2 Europe Corticosteroids Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Corticosteroids Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Corticosteroids Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Corticosteroids Sales Value (2021-2032)
  21. 6.9.2 South America Corticosteroids Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Corticosteroids Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Corticosteroids Sales Value Share by Country, 2025 VS 2032
7 Corticosteroids Country-level Sales and Value Analysis
  1. 7.1 Global Corticosteroids Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Corticosteroids Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Corticosteroids Sales by Country (2021-2032)
  4. 7.3.1 Global Corticosteroids Sales by Country (2021-2026)
  5. 7.3.2 Global Corticosteroids Sales by Country (2027-2032)
  6. 7.4 Global Corticosteroids Sales Value by Country (2021-2032)
  7. 7.4.1 Global Corticosteroids Sales Value by Country (2021-2026)
  8. 7.4.2 Global Corticosteroids Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Corticosteroids Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Corticosteroids Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Corticosteroids Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Corticosteroids Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Corticosteroids Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Corticosteroids Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Corticosteroids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Corticosteroids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Corticosteroids Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Corticosteroids Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Corticosteroids Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Corticosteroids Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Corticosteroids Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Corticosteroids Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Corticosteroids Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Corticosteroids Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Corticosteroids Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Corticosteroids Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Corticosteroids Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Corticosteroids Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Corticosteroids Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Corticosteroids Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Corticosteroids Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Corticosteroids Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Corticosteroids Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Corticosteroids Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Corticosteroids Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Corticosteroids Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Corticosteroids Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Corticosteroids Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Corticosteroids Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Corticosteroids Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Corticosteroids Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Corticosteroids Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Corticosteroids Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Corticosteroids Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Corticosteroids Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Corticosteroids Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Corticosteroids Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Corticosteroids Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Corticosteroids Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Corticosteroids Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Corticosteroids Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Corticosteroids Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Corticosteroids Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Corticosteroids Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Corticosteroids Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Corticosteroids Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Corticosteroids Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Corticosteroids Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Corticosteroids Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Corticosteroids Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Corticosteroids Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Corticosteroids Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Corticosteroids Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Corticosteroids Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Corticosteroids Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Corticosteroids Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Corticosteroids Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Corticosteroids Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Corticosteroids Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Corticosteroids Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Corticosteroids Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Corticosteroids Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Corticosteroids Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Corticosteroids Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Corticosteroids Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Corticosteroids Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Corticosteroids Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Corticosteroids Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Corticosteroids Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Corticosteroids Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Corticosteroids Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Corticosteroids Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Corticosteroids Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Corticosteroids Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Corticosteroids Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Corticosteroids Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Corticosteroids Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Corticosteroids Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Corticosteroids Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Corticosteroids Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Corticosteroids Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Corticosteroids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Corticosteroids Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Corticosteroids Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Corticosteroids Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Corticosteroids Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Corticosteroids Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Corticosteroids Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Corticosteroids Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Corticosteroids Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Corticosteroids Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Corticosteroids Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Corticosteroids Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Corticosteroids Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Corticosteroids Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Corticosteroids Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Sumitomo
  44. 8.8.1 Sumitomo Company Information
  45. 8.8.2 Sumitomo Business Overview
  46. 8.8.3 Sumitomo Corticosteroids Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sumitomo Corticosteroids Product Portfolio
  48. 8.8.5 Sumitomo Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Corticosteroids Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Corticosteroids Product Portfolio
  54. 8.9.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Corticosteroids Value Chain Analysis
  2. 9.1.1 Corticosteroids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Corticosteroids Sales Mode & Process
  6. 9.2 Corticosteroids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Corticosteroids Distributors
  9. 9.2.3 Corticosteroids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst